Eudaimonia Partners LLC Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Eudaimonia Partners LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,636 shares of the healthcare conglomerate's stock after selling 1,790 shares during the quarter. Eudaimonia Partners LLC's holdings in UnitedHealth Group were worth $1,914,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the 4th quarter worth about $26,000. CGC Financial Services LLC increased its stake in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock valued at $33,000 after purchasing an additional 51 shares during the period. LFA Lugano Financial Advisors SA increased its holdings in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate's stock valued at $35,000 after buying an additional 40 shares during the period. Finally, Annapolis Financial Services LLC boosted its position in UnitedHealth Group by 38.6% during the 3rd quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate's stock valued at $40,000 after acquiring an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company's stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of the company's stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on UNH shares. Cantor Fitzgerald reiterated an "overweight" rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 10th. Oppenheimer reaffirmed an "outperform" rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Monday. Barclays increased their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an "overweight" rating in a research note on Wednesday, April 17th. Finally, HSBC raised shares of UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 price objective for the company in a research report on Thursday, April 4th. Three analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $570.05.

UnitedHealth Group Stock Performance

NYSE UNH traded up $3.62 on Wednesday, reaching $517.50. 2,981,164 shares of the company's stock traded hands, compared to its average volume of 4,275,279. The firm has a market cap of $476.30 billion, a price-to-earnings ratio of 31.63, a P/E/G ratio of 1.48 and a beta of 0.55. The stock has a 50 day moving average price of $483.69 and a 200-day moving average price of $511.41. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.26 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group's dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.